| Q46959422 | Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy |
| Q43409321 | Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. |
| Q35043812 | Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian |
| Q34829290 | Diabetes: glycaemic control in type 2 (drug treatments). |
| Q24246084 | Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus |
| Q38754132 | Is gliclazide a sulfonylurea with difference? A review in 2016. |
| Q39420555 | Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations |
| Q27022613 | Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials |
| Q33438955 | Who should benefit from the use of alpha-glucosidase inhibitors? |